# Observational Safety Study of Etanercept (Enbrel) for Treatment of Psoriasis

> **NCT00322439** · — · COMPLETED · sponsor: **Amgen** · enrollment: 2511 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Etanercept

## Key facts

- **NCT ID:** NCT00322439
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05-01
- **Primary completion:** 2012-12-11
- **Final completion:** 2013-02-08
- **Target enrollment:** 2511 (ACTUAL)
- **Last updated:** 2018-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00322439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00322439, "Observational Safety Study of Etanercept (Enbrel) for Treatment of Psoriasis". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00322439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*